1. Home
  2. TRVG vs ZURA Comparison

TRVG vs ZURA Comparison

Compare TRVG & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo trivago N.V.

TRVG

trivago N.V.

HOLD

Current Price

$2.93

Market Cap

278.1M

Sector

Technology

ML Signal

HOLD

Logo Zura Bio Limited

ZURA

Zura Bio Limited

N/A

Current Price

$4.30

Market Cap

252.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRVG
ZURA
Founded
2005
2022
Country
Germany
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
278.1M
252.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TRVG
ZURA
Price
$2.93
$4.30
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$3.96
$11.38
AVG Volume (30 Days)
56.7K
369.0K
Earning Date
02-03-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$614,486,683.00
N/A
Revenue This Year
$18.36
N/A
Revenue Next Year
$9.18
N/A
P/E Ratio
$97.46
N/A
Revenue Growth
14.41
N/A
52 Week Low
$2.02
$0.97
52 Week High
$5.83
$4.68

Technical Indicators

Market Signals
Indicator
TRVG
ZURA
Relative Strength Index (RSI) 46.62 63.27
Support Level $2.82 $4.20
Resistance Level $3.15 $4.45
Average True Range (ATR) 0.11 0.23
MACD 0.00 0.04
Stochastic Oscillator 30.56 80.85

Price Performance

Historical Comparison
TRVG
ZURA

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and All other countries.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: